Cooperative Agreement U48DP005053

The National Center for Advancing Translational Sciences awarded the University of Pennsylvania $3.312 million on August 10, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to develop and test infrastructure for parent-child behavioral interventions addressing obesity in families. The project, titled "Research Redesign to Reduce Chronic Conditions in Families," combines the adult-focused resources of the University of Pennsylvania with the...

This Cooperative Agreement award from the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control (CFDA 93.136 - Injury Prevention and Control Research and State and Community Based Programs) provides $591,098.00 in funding to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, to evaluate the impact of the PHLHOUSING+ program on child welfare involvement. The 3-year project, with a...

The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Pennsylvania $808,720 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a longitudinal randomized controlled trial examining how unhealthy food restrictions and healthy food incentives on a monthly food benefit program affect diet quality and program experiences among low-income Americans. The study will enroll 357...

The University of Pennsylvania received a $1,581,298 Cooperative Agreement from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes program (CFDA 93.226) to establish the SCALE-LHS Coordinating Center ("Hub"). The SCALE-LHS Hub will serve four key functions: 1) coordinating network activities, 2) supporting equity-focused initiatives, 3) conducting annual evaluations of the 16 LHS E-STAR Centers and the overall network, and...

The National Institute on Aging awarded the University of Pennsylvania $811,172 on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct a five-year prospective observational study testing whether economic scarcity affects medication adherence and uptake of preventive services among older adults with chronic disease. The research enrolls 400 adults aged 50 years or older who receive Supplemental Nutrition Assistance Program (SNAP) benefits and are prescribed once-daily...

The National Institute of Environmental Health Sciences awarded the University of Pennsylvania $1,454,963 on June 1, 2026, under the Medical Library Assistance program (CFDA 93.879) to develop statistical methods for integrating irregularly collected longitudinal multi-modal data—electronic health record, patient-reported outcome, and mobile health data—into prediction models for individuals with chronic illnesses including diabetes, heart failure, cancer, and obesity. The project addresses...

The National Institute of Mental Health awarded the University of Pennsylvania $1.488 million on September 18, 2025, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate STEP-UP (Streamlining Telehealth for Expanded PrEP Utilization Through Community Partnerships), an implementation-effectiveness pilot study integrating telehealth pre-exposure prophylaxis delivery into community-based organizations serving individuals at elevated risk for HIV acquisition. Over...

Federal Project Grant Award Summary The University of Pennsylvania received a $457,596 Project Grant from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242), awarded August 1, 2025, with completion targeted for July 31, 2027. This research initiative will deliver a comprehensive analysis identifying key engagement characteristics that enhance the effectiveness of digital health interventions (DHIs) for HIV prevention and care among at-risk...

The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded The Pennsylvania State University $250,000 on September 30, 2026, under the Center for Substance Abuse Prevention Projects of Regional and National Significance program (CFDA 93.492). Penn State will deliver prevention training and technical assistance to at least 1,000 adults—including school administrators, teachers, counselors, student support personnel, prevention professionals,...

The National Institute for Minority Health and Health Disparities awarded The Trustees of the University of Pennsylvania $755,882 on August 18, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct a randomized controlled trial testing virtual disease management interventions for peripheral artery disease in low-socioeconomic-status communities. The project tests two separate components of a comprehensive virtual disease management platform designed for...